Breast Cancer–Associated Thrombotic Microangiopathy: The Paradox of Stable Scans and Unstable Blood

Cancer-associated thrombotic microangiopathy (TMA) is a rare and often fatal consequence of solid and hematologic malignancies. We report a 69-year-old woman with metastatic hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer who developed severe anemia without... View More